RAPT Therapeutics
IPORelentlessly focused on advancing treatments for patients with inflammatory and immunologic diseases
Public · San Francisco, United States · Founded 2015 · $497.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- rapt.com
- Total Funding
- $497.0M
- Last Round
- $250.0M Private EquityOct 2025
- Rounds
- 4
- Type
- Public
About
RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapeutics that target key drivers of the immune system for inflammatory and immunologic diseases, including food allergy.
Summary
RAPT Therapeutics is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $497.0M in total across 4 rounds, most recently a $250.0M Private Equity round in Oct 2025. Investors include GV.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...